[Alpha-2-macroglobulin in children with glomerular diseases (author's transl)]

Area of Science:

• Pediatric Nephrology
• Clinical Biochemistry
• Immunology

Background:

• Glomerular diseases in children can lead to complex physiological changes.
• Alpha-2-macroglobulin (alpha2-MG) is a key protease inhibitor with potential roles in renal pathology.
• Understanding biomarker levels is crucial for diagnosing and managing pediatric kidney conditions.

Purpose of the Study:

• To investigate serum and urine levels of alpha-2-macroglobulin (alpha2-MG) in children with various glomerular diseases.
• To compare alpha2-MG levels between healthy children and those with kidney disease.
• To evaluate the diagnostic and prognostic potential of alpha2-MG in pediatric glomerular diseases.

Main Methods:

• Serum and urine samples were collected from 33 children diagnosed with glomerular diseases and 26 healthy controls.
• Alpha-2-macroglobulin (alpha2-MG) concentrations were quantified using biochemical assays.
• Urinary alpha2-MG levels were assessed in relation to proteinuria and disease activity.

Main Results:

• Healthy children exhibited normal serum alpha2-MG levels (mean 301 mg%).
• No urinary alpha2-MG was detected in healthy children or in patients with proteinuria.
• Steroid-treated patients with idiopathic nephrotic syndrome showed significantly elevated serum alpha2-MG (up to 490 mg%).
• Serum alpha2-MG levels were normal in glomerulopathies without nephrotic syndrome.
• Urinary alpha2-MG concentrations correlated with the activity of the glomerular disease.

Conclusions:

• Serum alpha2-MG levels may be elevated in pediatric nephrotic syndrome, potentially due to steroid therapy or reactive protein synthesis.
• Urinary alpha2-MG is generally absent, even with proteinuria, in these conditions.
• Alpha-2-macroglobulin (alpha2-MG) determination in serum and urine shows promise as a tool for differential diagnosis and prognosis in pediatric glomerular diseases.